The Native Antigen Company (NAC) has released a highly purified cytomegalovirus (CMV) native antigen, which has been manufactured in response to the in vitro diagnostics (IVD) industry’s requirement for a cost-effective antigen that can demonstrate a high affinity for IgG and IgM. This latest antigen from NAC’s rapidly increasing portfolio also minimises cross-reactivity and lot-to-lot variation.
Launch Diagnostics is one of the major independent distributors in the U.K, providing high quality diagnostic reagents and instrumentation from world leading manufacturer’s to the Health Services of the United Kingdom, France, Belgium, Netherlands, Luxemburg and North Africa and to the Republic of Ireland through ACCUSAY Diagnostics.
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
Rome, Italy
10-11 April, 2025
Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025
Royal College Of Physicians Of Edinburgh
15 May, 2025
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
